Trial Profile
Comparative Study of Neoadjuvant Chemotherapy With and Without Zometa for Management of Locally Advanced Breast Cancers
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Zoledronic acid (Primary) ; Cyclophosphamide; Docetaxel; Doxorubicin
- Indications Breast cancer
- Focus Therapeutic Use
- Acronyms NEOZOL
- 12 Dec 2015 Status changed from completed to discontinued according to results presented at the 38th Annual San Antonio Breast Cancer Symposium.
- 12 Dec 2015 Results presented at the 38th Annual San Antonio Breast Cancer Symposium
- 19 Sep 2013 Planned end date changed from 1 Nov 2013 to 1 Feb 2014 as reported by ClinicalTrials.gov.